Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-04

FDA Approved: OMEPRAZOLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved Glenmark's supplemental application for omeprazole, a generic proton pump inhibitor, expanding or updating its approval for the marketed produc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omeprazole (Omeprazole)

Snippet

SUPPL AP for OMEPRAZOLE (OMEPRAZOLE)